Bethany Shoulders, Pharm.D., BCCCP

Bethany Shoulders

Clinical Assistant Professor

Pharmacotherapy and Translational Research



PHONE: 352-294-8780

CV: Link to CV



  • Pharm.D., University of Tennessee Health Science Center
  • PGY1 Pharmacy Practice Residency, The Johns Hopkins Hospital – Baltimore, MD
  • PGY2 Critical Care Pharmacy Residency, University of Pittsburgh Medical Center – Pittsburgh, PA

Biographical Sketch

Bethany Shoulders, Pharm.D., joined the College of Pharmacy as a clinical assistant professor in the department of pharmacotherapy and translational research in July 2016. She maintains a clinical practice site at the trauma ICU at UF Health Shands Hospital.

Shoulders received her Pharm.D. degree from the University of Tennessee Health Science Center in 2014. She then completed a pharmacy practice residency at The Johns Hopkins Hospital in Baltimore and travelled to Pittsburgh to complete her PGY2 critical care pharmacy practice residency with the University of Pittsburgh Medical Center. Her research endeavors during residency included evaluating intraoperative continuous infusion cefazolin in a cardiac surgery population and characterizing the guideline evidence behind off-label medication use in the intensive care unit.


  • Society of Critical Care Medicine
  • American College of Clinical Pharmacy
  • American Society of Health-System Pharmacists

Select Publications

Shoulders BR, Crow JR, Davis SL, et al. Impact of intraoperative continuous vs. intermittent cefazolin therapy on the incidence of surgical site infections after coronary artery bypass grafting. Pharmacotherapy 2016 Feb;36(2):166-73.

Magruder JT, Grimm JC, Dungan SP, Shah AS, Crow JR, Shoulders BR, Lester L, Barodka V. Continuous intraoperative cefazolin infusion may reduce surgical site infections during cardiac surgical procedures: a propensity-matched analysis. J Cardiothorac Vasc Anesth 2015 Dec;29(6):1582-7.

Shoulders BR, Franks AS, Barlow PB, Williams JD, Farland MZ. Impact of pharmacists’ interventions and simvastatin dose restrictions. Ann Pharmacother 2014;48(1):54-6.